Citations

Clear

116 citation(s) found for "Colby, Thomas".

Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment
Taniguchi, Hiroyuki , Ogura, Takashi , Johkoh, Takeshi , Fujimoto, Kiminori , Sumikawa, Hiromitsu , Kataoka, Kensuke , Baba, Tomohisa , Colby, Thomas V. , Kitaichi, Masanori, Kondoh, Yasuhiro

Mayo Clinic

Respirology | March 14, 2013 | Volume: 18 | Issue: 5 | Pages: 820-826

10.1111/resp.12082 | PMID 23489318 Get It

AbstractBackground and objectiveDespite significant recent progress in the understanding of idiopathic pulmonary fibrosis (IPF), the early phase of the disease is still poorly understood. We studied patients with IPF without pulmonary function impairment in order to determine the clinical features, natural history and key findings for physiological progression.MethodsTwenty‐five patients without pulmonary function impairment were identified from among patients with previously diagnosed IPF who underwent surgical lung biopsies between January 1997 and December 2006 at our institutions. ‘Without pulmonary function impairment’ was defined as both forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLco) >80% predicted. Patients diagnosed with IPF through multidisciplinary discussion based on the new IPF guidelines were the subjects of this study.ResultsSixteen patients had a confirmed diagnosis of IPF. Eleven patients presented with chest X‐ray abnormality found during an annual health examination. Seven patients were asymptomatic. Eleven patients showed physiological disease progression (median time; 19.9 ± 12.3 months) defined by a decline of at least 10% in FVC or at least 15% in DLco. Univariate analysis revealed that both usual interstitial pneumonia pattern and extent of honeycombing on high‐resolution computed tomography (HRCT) were factors associated with disease progression (odds ratio 5.634, 95% confidence interval 1.364–23.278; odds ratio 2.371/5%, 95% confidence interval 1.042–5.395).ConclusionsIPF patients without pulmonary function impairment have a progressive but slow clinical course. The existence and extent of honeycombing on HRCT are predictive of disease progression.
Encapsulated Versus Nonencapsulated Superficial Fatty Masses: A Proposed MR Imaging Classification
Liu, Patrick T., Colby, Thomas V. , Roberts, Catherine C.

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 180 | Issue: 5 | Pages: 1419-1422

10.2214/ajr.180.5.1801419 | PMID 12704061 Get It

Asthma and Associated Conditions: High-Resolution CT and Pathologic Findings
Silva, C. Isabela S., Colby, Thomas V. , Müller, Néstor L.

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 183 | Issue: 3 | Pages: 817-824

10.2214/ajr.183.3.1830817 | PMID 15333375 Get It

Lymphangioleiomyomatosis: Calling It What It Is: A Low-Grade, Destructive, Metastasizing Neoplasm
McCormack, Francis X. , Colby, Thomas V. , Moss, Joel , Travis, William D. , Henske, Elizabeth P. , McCormack, Francis X

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | December 17, 2012 | Volume: 186 | Issue: 12 | Pages: 1210-1212

10.1164/rccm.201205-0848oe | PMID 23250499 Get It

Prevention of Alveolar Destruction and Airspace Enlargement in a Mouse Model of Pulmonary Lymphangioleiomyomatosis (LAM)
Goncharova, Elena A. , Goncharov, Dmitry A. , Fehrenbach, Melane, Khavin, Irene, Ducka, Blerina, Hino, Okio , Colby, Thomas V. , Merrilees, Mervyn J., Haczku, Angela , Albelda, Steven Μ. , Krymskaya, Vera P.

Mayo Clinic

Science Translational Medicine | October 3, 2012 | Volume: 4 | Issue: 154 | Pages: No page available

10.1126/scitranslmed.3003840 | PMID 23035046 Get It

In a mouse model of the human disease pulmonary lymphangioleiomyomatosis, treatment with rapamycin plus simvastatin prevented alveolar space enlargement and growth of TSC2-null lesions.
Update for Pathologists on Idiopathic Interstitial Pneumonias
Larsen, Brandon T. , Colby, Thomas V.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | September 30, 2012 | Volume: 136 | Issue: 10 | Pages: 1234-1241

10.5858/arpa.2012-0225-ra | PMID 23020729 Get It

Context.—Idiopathic interstitial pneumonias are a subset of diffuse pulmonary interstitial diseases classified by international consensus in 2002 as idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, cryptogenic organizing pneumonia, acute interstitial pneumonia, respiratory bronchiolitis interstitial lung disease, desquamative interstitial pneumonia, and lymphoid interstitial pneumonia. Each is associated with a characteristic histopathologic pattern. In 2011, updated consensus guidelines were released for diagnosis and management of idiopathic pulmonary fibrosis. The entire group of idiopathic interstitial pneumonias is currently undergoing refinement, with updates expected in a forthcoming consensus classification. Many of these recent and anticipated changes are relevant to pathologists. Objectives.—To review international consensus guidelines for diagnosis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias and to discuss recent and expected future classification updates. Data Sources.—Published peer-reviewed literature and personal experience of the authors. Conclusions.—Diagnosis of idiopathic interstitial pneumonias by multidisciplinary discussion among clinicians, radiologists, and pathologists is now strongly encouraged. Diagnosis of idiopathic pulmonary fibrosis no longer requires surgical lung biopsy; high-resolution computed tomography is an acceptable surrogate. In the context of clinical trials, pathologists are being asked to assign levels of confidence for histologic diagnosis of usual interstitial pneumonia in patients with idiopathic pulmonary fibrosis. Acute exacerbation of idiopathic pulmonary fibrosis is now accepted and should be considered when acute lung injury is superimposed on a background of usual interstitial pneumonia. The updated classification of idiopathic interstitial pneumonias will include a separate category for rare entities, including lymphoid interstitial pneumonia and idiopathic pleuroparenchymal fibroelastosis.
CT Grading of Lung Disease in Lymphangioleiomyomatosis
Yao, Jianhua , Taveira‐DaSilva, Angelo M., Colby, Thomas V. , Moss, Joel

Mayo Clinic

American Journal of Roentgenology | September 20, 2012 | Volume: 199 | Issue: 4 | Pages: 787-793

10.2214/ajr.11.7888 | PMID 22997369 Get It

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group
Husain, Aliya N. , Colby, Thomas V. , Ordóǹez, Nelson G., Krausz, Thomas, Attanoos, Richard , Beasley, Mary Beth , Borczuk, Alain , Butnor, Kelly J. , Cagle, Philip T., Chirieac, Lucian R. , Đačić, Sanja , Fraire, Armando E., Galateau-Sallé, Françoise , Gibbs, A R, Gown, Allen M. , Hammar, Samuel P. , Litzky, Leslie A., Marchevsky, Alberto M. , Roggli, Victor L., Wick, Mark R. , Churg, Andrew , Nicholson, Andrew G. , Travis, William D.

Mayo Clinic

Archives of Pathology and Laboratory Medicine | August 28, 2012 | Volume: 137 | Issue: 5 | Pages: 647-667

10.5858/arpa.2012-0214-oa | PMID 22929121 Get It

Context .—Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. Objective .—To provide updated practical guidelines for the pathologic diagnosis of MM. Data Sources .—Pathologists involved in the International Mesothelioma Interest Group and others with an interest in the field contributed to this update. Reference material includes peer-reviewed publications and textbooks. Conclusions .—There was consensus opinion regarding (1) distinction of benign from malignant mesothelial proliferations (both epithelioid and spindle cell lesions), (2) cytologic diagnosis of MM, (3) key histologic features of pleural and peritoneal MM, (4) use of histochemical and immunohistochemical stains in the diagnosis and differential diagnosis of MM, (5) differentiation of epithelioid MM from various carcinomas (lung, breast, ovarian, and colonic adenocarcinomas, and squamous cell and renal cell carcinomas), (6) diagnosis of sarcomatoid mesothelioma, (7) use of molecular markers in the diagnosis of MM, (8) electron microscopy in the diagnosis of MM, and (9) some caveats and pitfalls in the diagnosis of MM. Immunohistochemical panels are integral to the diagnosis of MM, but the exact makeup of panels used is dependent on the differential diagnosis and on the antibodies available in a given laboratory. Immunohistochemical panels should contain both positive and negative markers. It is recommended that immunohistochemical markers have either sensitivity or specificity greater than 80% for the lesions in question. Interpretation of positivity generally should take into account the localization of the stain (eg, nuclear versus cytoplasmic) and the percentage of cells staining (>10% is suggested for cytoplasmic membranous markers). These guidelines are meant to be a practical reference for the pathologist.
Histopathologic Overlap between Fibrosing Mediastinitis and IgG4-Related Disease
Peikert, Tobias, Shrestha, Bijayee, Aubry, Marie Christine, Colby, Thomas V. , Ryu, Jay H. , Sekiguchi, Hiroshi , Smyrk, Thomas C. , Yi, Eunhee S. , Specks, Ulrich , Ryu, Jay H

Mayo Clinic

International Journal of Rheumatology | May 10, 2012 | Volume: 2012 | Issue: No issue available | Pages: 1-7

10.1155/2012/207056 | PMID 22654916 Get It

Fibrosing mediastinitis (FM) and IgG4-related disease (IgG4-RD) are two fibroinflammatory disorders with potentially overlapping clinical and radiological features. In this paper, we looked for histopathologic features of IgG4-RD and enumerated infiltrating IgG4-positive plasma cells within mediastinal tissue biopsies from FM patients. We identified 15 consecutive FM surgical mediastinal tissue biopsies between 1985 and 2006. All patients satisfied the clinical and radiological diagnostic criteria for FM. All patients had either serological or radiological evidence of prior histoplasmosis or granulomatous disease, respectively. Formalin-fixed paraffin-embedded tissue sections of all patients were stained for H&E, IgG, and IgG4. Three samples met the predefined diagnostic criteria for IgG4-RD. In addition, characteristic histopathologic changes of IgG4-RD in the absence of diagnostic numbers of tissue infiltrating IgG4-positive plasma cells were seen in a number of additional cases (storiform cell-rich fibrosis in 11 cases, lymphoplasmacytic infiltrate in 7 cases, and obliterative phlebitis/arteritis in 2 cases). We conclude that up to one-third of histoplasmosis or granulomatous-disease-associated FM cases demonstrate histopathological features of IgG4-RD spectrum. Whether these changes occur as the host immune response against Histoplasma or represent a manifestation of IgG4-RD remains to be determined. Studies to prospectively identify these cases and evaluate their therapeutic responses to glucocorticoids and/or other immunosuppressive agents such as rituximab are warranted.
Cryptogenic Constrictive Bronchiolitis: A Clinicopathologic Study
Kraft, Monica , Mortenson, Rebecca L., Colby, Thomas V. , Waldron, James A., King, Talmadge E. , Newman, Lee Scott

Mayo Clinic

American Review of Respiratory Disease | August 3, 2011 | Volume: 148 | Issue: 4_Part_1 | Pages: 1093-1101

10.1164/ajrccm/148.4_pt_1.1093 | PMID 8214931 Get It

Abstract Four women with a chronic respiratory illness characterized by chronic cough, dyspnea, mild to severe physiologic abnormalities, relatively normal chest radiographs, and lack of response to bronchodilators or prednisone were identified and prospectively evaluated. Constrictive bronchiolitis, defined as concentric narrowing of the bronchiolar lumen, mural scarring, smooth muscle hyperplasia, and mucus stasis, was the major histologic finding on open lung biopsy in all cases. Each presented with an illness clinically distinct from asthma, connective tissue disorders, occupational or environmental lung disease, bronchiectasis, diffuse panbronchiolitis, cystic fibrosis, and emphysema. None of the patients smoked cigarettes. None had clinical evidence of a recent viral lower respiratory tract infection. The physical examinations were normal except for rales heard on chest examination in two patients. Chest radiographs showed increased bronchovascular markings in three patients. Lung function was normal in one patient, two of the patients had a reduced diffusing capacity associated with moderate hypoxemia and an obstructive ventilatory defect, and one patient exhibited a mixture of restrictive and obstructive defects. None have experienced significant progression of their disease over 1 to 5 yr of follow-up. However, complete return to normal function did not occur. We hypothesize that patients with the constellation of findings described represent a distinct and definable clinicopathologic entity and further clarifies the spectrum of “small airways disease.” Establishing the diagnosis appears important for prognostic and possibly therapeutic reasons.